- Home
- GRDN
GRDN
Guardian Pharmacy Services Inc. Class A Common Stock
as 11-15-2024 4:00pm EST
| Founded: | 2004 | Country: | United States |
| Employees: | N/A | City: | N/A |
| Market Cap: | 1.1B | IPO Year: | 2024 |
| Target Price: | $22.50 | AVG Volume (30 days): | 141.3K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 2 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -1.55 | EPS Growth: | N/A |
| 52 Week Low/High: | $14.16 - $23.05 | Next Earning Date: | 11-12-2024 |
| Revenue: | $1,170,907,000 | Revenue Growth: | 16.86% |
| Revenue Growth (this year): | 16.14% | Revenue Growth (next year): | 10.62% |
Latest Guardian Pharmacy Services Inc. Class A Common Stock News
GRDN Breaking Stock News: Dive into GRDN Ticker-Specific Updates for Smart Investing
MT Newswires
2 days ago
Truist Raises Price Target on Guardian Pharmacy Services to $24 From $22, Keeps Buy Rating
MT Newswires
4 days ago
Sector Update: Health Care Stocks Rise Premarket Wednesday
MT Newswires
4 days ago
Guardian Pharmacy Reports Q3 Loss, Revenue Increases
Associated Press Finance
4 days ago
Guardian Pharmacy: Q3 Earnings Snapshot
Business Wire
5 days ago
Guardian Pharmacy Services, Inc. Reports Third Quarter 2024 Financial Results
Business Wire
17 days ago
Guardian Pharmacy Services, Inc. to Participate in Upcoming Investor Conference
Business Wire
18 days ago
Guardian Pharmacy Services, Inc. to Report Third Quarter 2024 Financial Results and Host Conference Call
Benzinga
a month ago
Newly Listed Guardian Pharmacy Is Well Positioned In Highly Fragmented Market, Analyst Initiates With Buy Rating
Compare GRDN vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "GRDN Guardian Pharmacy Services Inc. Class A Common Stock - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.